GASTON-DREYFUS REMI purchased 10.6% of their position (135.56K shares) of BIONIK LABORATORIES CORP. on the open market
Open‑market purchases signal personal conviction — classified as a moderate purchase.
P · 1 purchase
Filed: 12/13/2021ACC: 0001104659-21-149123
Director10% Owner
Since Jul 2018
+135.56K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
135.56K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
+135.56K
Price / share
—
Trade value
—
% of position
10.6%
3/26/2021
1.28M→1.42M
Total
Net shares
+135.56K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 3/26/2021 | P · Purchase | +135.56K | — | — | 10.6% | 1.28M | 1.42M |
| Total | +135.56K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001 per share
DirectShares owned61.26K
Total
61.26K direct61.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 61.26K | Direct |
| Total | 61.26K | 61.26K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported